Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma

Antonio Zizzi, Maria Alessandra Montironi, Roberta Mazzucchelli, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Nicola Paone, Paolo Castellini, Rodolfo Montironi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background/Aims: The chromatin remodeler DAXX, a predominantly nuclear protein, regulates the status of chromatin organization. The aim of this exploratory immunohistochemical study was to evaluate DAXX protein expression in high grade invasive urothelial carcinoma (UC) of the bladder as a biological regulator of aggressiveness.Methods: Quantitative analysis was made on DAXX immunostained nuclei in tissue sections from 5 cases of bladder normal urothelium (NU) and 5 cases of bladder pT1 UC. Carcinoma in situ (CIS) and high grade papillary carcinoma (HGPCa) were identified in 2 out of 5 UC cases.Results: The nuclei in UC show an open configuration of the chromatin composed of granules varying in size and distribution and a mean nuclear area 1.7 times greater than that in NU (UC: mean and SD 24.4 ± 11.4 square microns; NU: 14.8 6.5 square microns. The differences are statistically significant). 70% of the NU nuclei are immunostained, whereas 90% of UC nuclei are positive. The mean gray level value in UC, related to the intensity of nuclear immunostaining, is lower than in NU by a factor of 0.94 (UC: mean and SD 100 ± 15; NU: 106 ± 15. The differences are statistically significant). In particular, the value in the nuclei adjacent to the stroma in UC is slightly lower than in the intermediate cell layers by factor of 0.98, whereas in NU it is slightly greater by a factor 1.02 and 1.04 compared to the intermediate and superficial cell layers. The values in CIS and HGPCa are similar to those in UC.Conclusions: The quantitative immunohistochemical analysis shows an altered protein expression of chromatin remodeler DAXX in UC and in its preinvasive phases, when compared to NU. DAXX evaluation, if associated with markers related to global DNA methylation and histone acetylation, could be used in clinical practice as a marker of aggressiveness.Virtual slides: The virtual slides for this article can be found here:. http://www.diagnosticpathology.diagnomx.eu/vs/1398457297102379.

Original languageEnglish
Article number111
JournalDiagnostic Pathology
Volume8
Issue number1
DOIs
StatePublished - Jul 2 2013

Fingerprint

Urothelium
Chromatin
Carcinoma
Urinary Bladder
Papillary Carcinoma
Carcinoma in Situ
DNA Methylation
Acetylation
Nuclear Proteins
Histones
Proteins

Keywords

  • Biological regulator
  • Chromatin remodeler DAXX
  • Urothelial carcinoma
  • Urothelium

ASJC Scopus subject areas

  • Histology
  • Pathology and Forensic Medicine

Cite this

Zizzi, A., Montironi, M. A., Mazzucchelli, R., Scarpelli, M., Lopez-Beltran, A., Cheng, L., ... Montironi, R. (2013). Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma. Diagnostic Pathology, 8(1), [111]. https://doi.org/10.1186/1746-1596-8-111

Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma. / Zizzi, Antonio; Montironi, Maria Alessandra; Mazzucchelli, Roberta; Scarpelli, Marina; Lopez-Beltran, Antonio; Cheng, Liang; Paone, Nicola; Castellini, Paolo; Montironi, Rodolfo.

In: Diagnostic Pathology, Vol. 8, No. 1, 111, 02.07.2013.

Research output: Contribution to journalArticle

Zizzi, A, Montironi, MA, Mazzucchelli, R, Scarpelli, M, Lopez-Beltran, A, Cheng, L, Paone, N, Castellini, P & Montironi, R 2013, 'Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma', Diagnostic Pathology, vol. 8, no. 1, 111. https://doi.org/10.1186/1746-1596-8-111
Zizzi, Antonio ; Montironi, Maria Alessandra ; Mazzucchelli, Roberta ; Scarpelli, Marina ; Lopez-Beltran, Antonio ; Cheng, Liang ; Paone, Nicola ; Castellini, Paolo ; Montironi, Rodolfo. / Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma. In: Diagnostic Pathology. 2013 ; Vol. 8, No. 1.
@article{dd1366b829a24a7397e33c6d84890422,
title = "Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma",
abstract = "Background/Aims: The chromatin remodeler DAXX, a predominantly nuclear protein, regulates the status of chromatin organization. The aim of this exploratory immunohistochemical study was to evaluate DAXX protein expression in high grade invasive urothelial carcinoma (UC) of the bladder as a biological regulator of aggressiveness.Methods: Quantitative analysis was made on DAXX immunostained nuclei in tissue sections from 5 cases of bladder normal urothelium (NU) and 5 cases of bladder pT1 UC. Carcinoma in situ (CIS) and high grade papillary carcinoma (HGPCa) were identified in 2 out of 5 UC cases.Results: The nuclei in UC show an open configuration of the chromatin composed of granules varying in size and distribution and a mean nuclear area 1.7 times greater than that in NU (UC: mean and SD 24.4 ± 11.4 square microns; NU: 14.8 6.5 square microns. The differences are statistically significant). 70{\%} of the NU nuclei are immunostained, whereas 90{\%} of UC nuclei are positive. The mean gray level value in UC, related to the intensity of nuclear immunostaining, is lower than in NU by a factor of 0.94 (UC: mean and SD 100 ± 15; NU: 106 ± 15. The differences are statistically significant). In particular, the value in the nuclei adjacent to the stroma in UC is slightly lower than in the intermediate cell layers by factor of 0.98, whereas in NU it is slightly greater by a factor 1.02 and 1.04 compared to the intermediate and superficial cell layers. The values in CIS and HGPCa are similar to those in UC.Conclusions: The quantitative immunohistochemical analysis shows an altered protein expression of chromatin remodeler DAXX in UC and in its preinvasive phases, when compared to NU. DAXX evaluation, if associated with markers related to global DNA methylation and histone acetylation, could be used in clinical practice as a marker of aggressiveness.Virtual slides: The virtual slides for this article can be found here:. http://www.diagnosticpathology.diagnomx.eu/vs/1398457297102379.",
keywords = "Biological regulator, Chromatin remodeler DAXX, Urothelial carcinoma, Urothelium",
author = "Antonio Zizzi and Montironi, {Maria Alessandra} and Roberta Mazzucchelli and Marina Scarpelli and Antonio Lopez-Beltran and Liang Cheng and Nicola Paone and Paolo Castellini and Rodolfo Montironi",
year = "2013",
month = "7",
day = "2",
doi = "10.1186/1746-1596-8-111",
language = "English",
volume = "8",
journal = "Diagnostic Pathology",
issn = "1746-1596",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma

AU - Zizzi, Antonio

AU - Montironi, Maria Alessandra

AU - Mazzucchelli, Roberta

AU - Scarpelli, Marina

AU - Lopez-Beltran, Antonio

AU - Cheng, Liang

AU - Paone, Nicola

AU - Castellini, Paolo

AU - Montironi, Rodolfo

PY - 2013/7/2

Y1 - 2013/7/2

N2 - Background/Aims: The chromatin remodeler DAXX, a predominantly nuclear protein, regulates the status of chromatin organization. The aim of this exploratory immunohistochemical study was to evaluate DAXX protein expression in high grade invasive urothelial carcinoma (UC) of the bladder as a biological regulator of aggressiveness.Methods: Quantitative analysis was made on DAXX immunostained nuclei in tissue sections from 5 cases of bladder normal urothelium (NU) and 5 cases of bladder pT1 UC. Carcinoma in situ (CIS) and high grade papillary carcinoma (HGPCa) were identified in 2 out of 5 UC cases.Results: The nuclei in UC show an open configuration of the chromatin composed of granules varying in size and distribution and a mean nuclear area 1.7 times greater than that in NU (UC: mean and SD 24.4 ± 11.4 square microns; NU: 14.8 6.5 square microns. The differences are statistically significant). 70% of the NU nuclei are immunostained, whereas 90% of UC nuclei are positive. The mean gray level value in UC, related to the intensity of nuclear immunostaining, is lower than in NU by a factor of 0.94 (UC: mean and SD 100 ± 15; NU: 106 ± 15. The differences are statistically significant). In particular, the value in the nuclei adjacent to the stroma in UC is slightly lower than in the intermediate cell layers by factor of 0.98, whereas in NU it is slightly greater by a factor 1.02 and 1.04 compared to the intermediate and superficial cell layers. The values in CIS and HGPCa are similar to those in UC.Conclusions: The quantitative immunohistochemical analysis shows an altered protein expression of chromatin remodeler DAXX in UC and in its preinvasive phases, when compared to NU. DAXX evaluation, if associated with markers related to global DNA methylation and histone acetylation, could be used in clinical practice as a marker of aggressiveness.Virtual slides: The virtual slides for this article can be found here:. http://www.diagnosticpathology.diagnomx.eu/vs/1398457297102379.

AB - Background/Aims: The chromatin remodeler DAXX, a predominantly nuclear protein, regulates the status of chromatin organization. The aim of this exploratory immunohistochemical study was to evaluate DAXX protein expression in high grade invasive urothelial carcinoma (UC) of the bladder as a biological regulator of aggressiveness.Methods: Quantitative analysis was made on DAXX immunostained nuclei in tissue sections from 5 cases of bladder normal urothelium (NU) and 5 cases of bladder pT1 UC. Carcinoma in situ (CIS) and high grade papillary carcinoma (HGPCa) were identified in 2 out of 5 UC cases.Results: The nuclei in UC show an open configuration of the chromatin composed of granules varying in size and distribution and a mean nuclear area 1.7 times greater than that in NU (UC: mean and SD 24.4 ± 11.4 square microns; NU: 14.8 6.5 square microns. The differences are statistically significant). 70% of the NU nuclei are immunostained, whereas 90% of UC nuclei are positive. The mean gray level value in UC, related to the intensity of nuclear immunostaining, is lower than in NU by a factor of 0.94 (UC: mean and SD 100 ± 15; NU: 106 ± 15. The differences are statistically significant). In particular, the value in the nuclei adjacent to the stroma in UC is slightly lower than in the intermediate cell layers by factor of 0.98, whereas in NU it is slightly greater by a factor 1.02 and 1.04 compared to the intermediate and superficial cell layers. The values in CIS and HGPCa are similar to those in UC.Conclusions: The quantitative immunohistochemical analysis shows an altered protein expression of chromatin remodeler DAXX in UC and in its preinvasive phases, when compared to NU. DAXX evaluation, if associated with markers related to global DNA methylation and histone acetylation, could be used in clinical practice as a marker of aggressiveness.Virtual slides: The virtual slides for this article can be found here:. http://www.diagnosticpathology.diagnomx.eu/vs/1398457297102379.

KW - Biological regulator

KW - Chromatin remodeler DAXX

KW - Urothelial carcinoma

KW - Urothelium

UR - http://www.scopus.com/inward/record.url?scp=84879810712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879810712&partnerID=8YFLogxK

U2 - 10.1186/1746-1596-8-111

DO - 10.1186/1746-1596-8-111

M3 - Article

C2 - 23819605

AN - SCOPUS:84879810712

VL - 8

JO - Diagnostic Pathology

JF - Diagnostic Pathology

SN - 1746-1596

IS - 1

M1 - 111

ER -